French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
On August 31, 2004, Olympus France withdrew from the market lot 1275 (per 01.04.05) of the in vitro diagnostic medical device called Olympus IgM - reference OSR6146 following the detection of a poor detection of the phenomenon of This device is intended for the determination of immunoglobulin M (IgM) in human serum and plasma on Olympus analyzers.